Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Clinical and Translational Science
|
March 2, 2022
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
Laura Oggianu, Giorgio Di Dato, Giorgina Mangano, et al.
Clinical and Translational Science
|
June 17, 2025
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning
Ananth Kadambi, Elke H J Krekels, Antal Martinecz, et al.
Journal of Theoretical Biology
|
December 5, 2012
A mathematical model of the human menstrual cycle for the administration of GnRH analogues
Susanna Röblitz, Claudia Stötzel, Peter Deuflhard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-Hydroxypropylamide
Niyanta Kumar, Vaishali Dixit, Howard Burt, et al.
Clinical Pharmacology in Drug Development
|
March 27, 2025
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein Inhibition
Hongxia Jia, T Eric Ballard, Liming Zhang, et al.
Journal of Translational Medicine
|
August 22, 2014
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
Jiandong Wang, Xiaoli Ma, Hannah M Jones, et al.
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib
Ian E Templeton, Karen Rowland-Yeo, Hannah M Jones, et al.
The AAPS Journal
|
November 4, 2025
Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic Model
Harry P Moore, Kuan-Fu Chen, Aki T Heikkinen, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond
Hugh A Barton, Yurong Lai, Theunis C Goosen, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim
Karen Cornelissen, John H Rex, Daniela Zinzi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Clinical and Translational Science
|
March 2, 2022
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
Laura Oggianu, Giorgio Di Dato, Giorgina Mangano, et al.
Clinical and Translational Science
|
June 17, 2025
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning
Ananth Kadambi, Elke H J Krekels, Antal Martinecz, et al.
Journal of Theoretical Biology
|
December 5, 2012
A mathematical model of the human menstrual cycle for the administration of GnRH analogues
Susanna Röblitz, Claudia Stötzel, Peter Deuflhard, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-Hydroxypropylamide
Niyanta Kumar, Vaishali Dixit, Howard Burt, et al.
Clinical Pharmacology in Drug Development
|
March 27, 2025
Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P-Glycoprotein Inhibition
Hongxia Jia, T Eric Ballard, Liming Zhang, et al.
Journal of Translational Medicine
|
August 22, 2014
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
Jiandong Wang, Xiaoli Ma, Hannah M Jones, et al.
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib
Ian E Templeton, Karen Rowland-Yeo, Hannah M Jones, et al.
The AAPS Journal
|
November 4, 2025
Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic Model
Harry P Moore, Kuan-Fu Chen, Aki T Heikkinen, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond
Hugh A Barton, Yurong Lai, Theunis C Goosen, et al.
Antimicrobial Agents and Chemotherapy
|
April 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim
Karen Cornelissen, John H Rex, Daniela Zinzi, et al.
Page
of 10